Precigen is undergoing a significant digital transformation as it transitions from a discovery and clinical-stage biotechnology company to a commercial-stage biopharmaceutical entity. This strategic shift involves implementing robust systems and workflows to support the commercialization of its advanced gene and cell therapies, particularly PAPZIMEOS. The company focuses on digitizing its proprietary AdenoVerse® and UltraCAR-T® platforms, alongside advanced manufacturing processes like UltraPorator®, to deliver precision medicines to patients.
This transformation creates critical dependencies on integrated data systems, automated manufacturing controls, and compliant digital workflows. Challenges arise in maintaining data integrity across clinical trials, ensuring real-time visibility in specialized cold chain logistics, and upholding stringent GxP compliance standards throughout the product lifecycle. This page will analyze Precigen’s key digital initiatives, the operational challenges they introduce, and where sellers can engage to provide value.
Precigen Snapshot
Headquarters: Germantown, United States
Number of employees: Not publicly available
Public or private: Public
Business model: B2B
Website: https://www.precigen.com
Precigen ICP and Buying Roles
Precigen sells to clinical research organizations and healthcare providers with specialized needs for advanced gene and cell therapy treatments.
Precigen also sells to specialized biopharmaceutical partners for co-development or licensing of its therapeutic platforms.
Who drives buying decisions
- Chief Medical Officer → Oversees clinical trial design and patient treatment protocols.
- Head of Manufacturing → Manages bioprocess development and facility operations.
- Head of Regulatory Affairs → Ensures compliance with FDA and EMA regulations for product approval and manufacturing.
- Head of Supply Chain → Directs logistics and distribution for sensitive biological products.
Key Digital Transformation Initiatives at Precigen (At a Glance)
- Establishing Commercial Operations for PAPZIMEOS: Launching sales, marketing, and patient support systems for its first FDA-approved gene therapy.
- Digitizing Rapid Biomanufacturing Processes: Automating process controls and data capture for accelerated cell and gene therapy production.
- Streamlining Clinical Trial Data Management: Implementing electronic systems for collecting, analyzing, and submitting clinical trial data to regulatory bodies.
- Integrating R&D Data Analytics: Centralizing and analyzing diverse research data from genomics and lab experiments to inform drug development.
- Digitalizing GxP Quality Management Systems: Transitioning manual quality processes to electronic platforms for regulatory adherence and audit readiness.
- Orchestrating Specialized Cold Chain Logistics: Implementing advanced tracking and monitoring systems for temperature-sensitive cell and gene therapy distribution.
Where Precigen’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Electronic Quality Management Systems | Digitalizing GxP Quality Management Systems: manual document control generates version control conflicts. | Head of Regulatory Affairs, Head of Quality Assurance, Head of Manufacturing | Enforce standardized document workflows and revision histories. |
| Digitalizing GxP Quality Management Systems: audit trails do not capture all process changes automatically. | Head of Quality Assurance, Head of IT | Automate audit log generation for all system interactions and changes. | |
| Digitalizing GxP Quality Management Systems: training records require manual updates and verification. | Head of Human Resources, Head of Quality Assurance | Standardize digital training assignment and completion tracking. | |
| Clinical Trial Management Software | Streamlining Clinical Trial Data Management: inconsistent data entry occurs across multiple study sites. | Head of Clinical Operations, Clinical Data Manager | Validate data at point of entry in electronic data capture systems. |
| Streamlining Clinical Trial Data Management: regulatory submissions require extensive manual data compilation. | Head of Regulatory Affairs, Clinical Data Manager | Standardize data extraction and reporting for BLA submission packages. | |
| Streamlining Clinical Trial Data Management: patient consent forms are not consistently tracked digitally. | Head of Clinical Operations, Legal Counsel | Enforce digital consent capture and version control. | |
| Biomanufacturing Execution Systems | Digitizing Rapid Biomanufacturing Processes: real-time process parameters do not sync with batch records. | Head of Manufacturing, Process Engineer | Route manufacturing data directly from equipment to electronic batch records. |
| Digitizing Rapid Biomanufacturing Processes: manual equipment calibration generates compliance risks. | Head of Manufacturing, Validation Engineer | Standardize automated equipment calibration schedules and logging. | |
| Digitizing Rapid Biomanufacturing Processes: raw material tracing fails across production stages. | Head of Supply Chain, Head of Manufacturing | Enforce end-to-end digital tracking of raw materials within the MES. | |
| Cold Chain Logistics Platforms | Orchestrating Specialized Cold Chain Logistics: temperature deviations occur during transit. | Head of Supply Chain, Logistics Manager | Detect temperature excursions with real-time sensor data. |
| Orchestrating Specialized Cold Chain Logistics: patient-specific shipments lack precise tracking updates. | Head of Supply Chain, Patient Services Manager | Standardize GPS location and condition monitoring for each shipment. | |
| Orchestrating Specialized Cold Chain Logistics: inventory reconciliation faces delays due to fragmented data. | Head of Supply Chain, Inventory Manager | Aggregate real-time inventory data from various storage locations. |
Identify when companies like Precigen are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Precigen’s digital transformation unique
Precigen’s digital transformation specifically prioritizes the integration of advanced manufacturing technologies with stringent GxP compliance requirements. Their approach focuses on creating rapid, decentralized production capabilities for highly individualized cell and gene therapies, which demands specialized software and hardware solutions beyond typical pharmaceutical manufacturing. This necessitates a unique emphasis on real-time process control and end-to-end digital traceability to ensure both product efficacy and patient safety for highly sensitive biological materials. The commercialization of PAPZIMEOS amplifies the need for integrated systems that connect R&D insights with market distribution, adding another layer of complexity.
Precigen’s Digital Transformation: Operational Breakdown
DT Initiative 1: Establishing Commercial Operations for PAPZIMEOS
What the company is doing
Precigen is building out its commercial infrastructure to support the launch and ongoing distribution of PAPZIMEOS. This involves setting up systems for order management, customer relationship management, and patient access programs. The company establishes channels for product distribution and post-market surveillance.
Who owns this
- Chief Commercial Officer
- Head of Sales Operations
- Head of Patient Services
- Head of Regulatory Affairs
Where It Fails
- Customer relationship management (CRM) systems do not integrate patient support case data.
- Order processing workflows require manual validation of insurance information.
- Inventory management systems do not communicate real-time stock levels for distribution centers.
- Post-market surveillance data fails to propagate into pharmacovigilance reporting systems.
Talk track
Noticed Precigen is establishing commercial operations for PAPZIMEOS. Been looking at how some biopharma teams are integrating patient support data directly into CRM systems instead of managing it separately, can share what’s working if useful.
DT Initiative 2: Digitizing Rapid Biomanufacturing Processes
What the company is doing
Precigen implements advanced automation and data capture within its manufacturing facilities, including its UltraPorator® system. This effort aims to accelerate the production of cell and gene therapies by digitizing process controls and integrating real-time operational data. The company focuses on ensuring consistency and scalability for its proprietary AdenoVerse® and UltraCAR-T® platforms.
Who owns this
- Head of Manufacturing
- VP, Process Development
- Validation Engineer
- Head of Quality Control
Where It Fails
- Automated bioreactor data does not synchronize with electronic batch records.
- Process monitoring sensors trigger false alarms when thresholds are met.
- Equipment maintenance schedules rely on manual tracking in the enterprise resource planning (ERP) system.
- Raw material lot numbers fail to trace automatically through the manufacturing execution system (MES).
Talk track
Saw Precigen is digitizing rapid biomanufacturing processes. Been looking at how some advanced therapy manufacturers are linking real-time process data directly to batch records instead of manual input, happy to share what we’re seeing.
DT Initiative 3: Streamlining Clinical Trial Data Management
What the company is doing
Precigen is enhancing its systems for collecting, managing, and analyzing data from its clinical trials. This includes efforts to standardize electronic data capture (EDC), improve data quality, and prepare comprehensive regulatory submissions. The company ensures compliance with Good Clinical Practice (GCP) guidelines.
Who owns this
- Head of Clinical Operations
- Clinical Data Manager
- Head of Biostatistics
- Head of Regulatory Affairs
Where It Fails
- Electronic data capture (EDC) systems produce inconsistencies during data transfers to statistical analysis software.
- Clinical trial management system (CTMS) workflows do not automatically flag overdue monitoring visits.
- Regulatory information management systems (RIMS) lack automatic version control for clinical study reports.
- Patient reported outcome (PRO) data does not integrate seamlessly with clinical trial databases.
Talk track
Looks like Precigen is streamlining clinical trial data management. Been seeing teams validate incoming data at the point of collection instead of correcting errors later, can share what’s working if useful.
DT Initiative 4: Digitalizing GxP Quality Management Systems
What the company is doing
Precigen transitions its quality management processes from manual or paper-based systems to electronic quality management systems (eQMS). This initiative covers document control, training management, deviation handling, corrective and preventive actions (CAPA), and audit management. The company aims to ensure continuous GxP compliance and audit readiness.
Who owns this
- Head of Quality Assurance
- Quality Systems Manager
- Head of Regulatory Affairs
- Compliance Officer
Where It Fails
- Document control workflows allow unapproved versions to circulate before final sign-off.
- Training records for staff do not automatically update completion status in the learning management system (LMS).
- Deviation investigations lack automated routing for timely review and approval.
- Audit management systems fail to link findings directly to corresponding corrective action preventive action (CAPA) records.
Talk track
Noticed Precigen is digitalizing GxP Quality Management Systems. Been looking at how some biopharma organizations enforce automated routing for deviation investigations instead of manual assignments, happy to share what we’re seeing.
Who Should Target Precigen Right Now
This account is relevant for:
- Electronic Quality Management System (eQMS) providers
- Clinical Trial Management System (CTMS) and EDC platform vendors
- Biomanufacturing Execution System (MES) and process control software vendors
- Specialized Cold Chain Logistics and Visibility platform providers
- Biopharmaceutical Data Integration and Analytics solution providers
- Regulatory Information Management System (RIMS) vendors
Not a fit for:
- Basic office productivity software providers
- Generic IT infrastructure consultants without biotech specialization
- Standard enterprise resource planning (ERP) vendors lacking GxP focus
- Consumer-facing marketing automation platforms
- General human resources management systems
- Physical security system vendors
When Precigen Is Worth Prioritizing
Prioritize if:
- You sell electronic quality management solutions that automate document control and deviation workflows in GxP environments.
- You sell clinical trial management platforms that enforce data quality standards during electronic data capture.
- You sell biomanufacturing execution systems that integrate real-time process data with electronic batch records.
- You sell specialized cold chain logistics platforms that provide real-time temperature monitoring and shipment tracking for patient-specific therapies.
- You sell data integration and analytics tools that centralize diverse R&D data for accelerated drug discovery in biopharma.
- You sell regulatory information management systems that automate the compilation of clinical data for BLA submissions.
Deprioritize if:
- Your solution does not address specific GxP compliance breakdowns or manufacturing automation failures.
- Your product is limited to basic data storage without advanced integration or validation capabilities.
- Your offering is not built for the unique demands of cell and gene therapy R&D, manufacturing, or logistics.
- Your solution focuses on general business processes rather than specialized biopharmaceutical workflows.
Who Can Sell to Precigen Right Now
Electronic Quality Management Systems
Veeva Systems - This company provides cloud-based software for the global life sciences industry, including quality management and regulatory solutions.
Why they are relevant: Precigen faces manual document control that generates version conflicts within its GxP quality management systems. Veeva QualityDocs can centralize document management, enforce version control, and automate review-and-approval workflows, ensuring compliance and reducing human error.
MasterControl - This company offers a comprehensive quality management system designed for regulated industries like life sciences.
Why they are relevant: Precigen's training records require manual updates and verification within its GxP quality management systems. MasterControl Training automates assignment, tracking, and verification of employee training, ensuring all personnel remain compliant with current protocols.
TrackWise (Sparta Systems, now Honeywell HLS) - This company providesPrecigen is undergoing a significant digital transformation as it transitions from a discovery and clinical-stage biotechnology company to a commercial-stage biopharmaceutical entity. This strategic shift involves implementing robust systems and workflows to support the commercialization of its advanced gene and cell therapies, particularly PAPZIMEOS. The company focuses on digitizing its proprietary AdenoVerse® and UltraCAR-T® platforms, alongside advanced manufacturing processes like UltraPorator®, to deliver precision medicines to patients.
This transformation creates critical dependencies on integrated data systems, automated manufacturing controls, and compliant digital workflows. Challenges arise in maintaining data integrity across clinical trials, ensuring real-time visibility in specialized cold chain logistics, and upholding stringent GxP compliance standards throughout the product lifecycle. This page will analyze Precigen’s key digital initiatives, the operational challenges they introduce, and where sellers can engage to provide value.
Precigen Snapshot
Headquarters: Germantown, United States
Number of employees: Not publicly available
Public or private: Public
Business model: B2B
Website: https://www.precigen.com
Precigen ICP and Buying Roles
Precigen sells to clinical research organizations and healthcare providers with specialized needs for advanced gene and cell therapy treatments.
Precigen also sells to specialized biopharmaceutical partners for co-development or licensing of its therapeutic platforms.
Who drives buying decisions
- Chief Medical Officer → Oversees clinical trial design and patient treatment protocols.
- Head of Manufacturing → Manages bioprocess development and facility operations.
- Head of Regulatory Affairs → Ensures compliance with FDA and EMA regulations for product approval and manufacturing.
- Head of Supply Chain → Directs logistics and distribution for sensitive biological products.
Key Digital Transformation Initiatives at Precigen (At a Glance)
- Establishing Commercial Operations for PAPZIMEOS: Launching sales, marketing, and patient support systems for its first FDA-approved gene therapy.
- Digitizing Rapid Biomanufacturing Processes: Automating process controls and data capture for accelerated cell and gene therapy production.
- Streamlining Clinical Trial Data Management: Implementing electronic systems for collecting, analyzing, and submitting clinical trial data to regulatory bodies.
- Integrating R&D Data Analytics: Centralizing and analyzing diverse research data from genomics and lab experiments to inform drug development.
- Digitalizing GxP Quality Management Systems: Transitioning manual quality processes to electronic platforms for regulatory adherence and audit readiness.
- Orchestrating Specialized Cold Chain Logistics: Implementing advanced tracking and monitoring systems for temperature-sensitive cell and gene therapy distribution.
Where Precigen’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Electronic Quality Management Systems | Digitalizing GxP Quality Management Systems: manual document control generates version control conflicts. | Head of Regulatory Affairs, Head of Quality Assurance, Head of Manufacturing | Enforce standardized document workflows and revision histories. |
| Digitalizing GxP Quality Management Systems: audit trails do not capture all process changes automatically. | Head of Quality Assurance, Head of IT | Automate audit log generation for all system interactions and changes. | |
| Digitalizing GxP Quality Management Systems: training records require manual updates and verification. | Head of Human Resources, Head of Quality Assurance | Standardize digital training assignment and completion tracking. | |
| Clinical Trial Management Software | Streamlining Clinical Trial Data Management: inconsistent data entry occurs across multiple study sites. | Head of Clinical Operations, Clinical Data Manager | Validate data at point of entry in electronic data capture systems. |
| Streamlining Clinical Trial Data Management: regulatory submissions require extensive manual data compilation. | Head of Regulatory Affairs, Clinical Data Manager | Standardize data extraction and reporting for BLA submission packages. | |
| Streamlining Clinical Trial Data Management: patient consent forms are not consistently tracked digitally. | Head of Clinical Operations, Legal Counsel | Enforce digital consent capture and version control. | |
| Biomanufacturing Execution Systems | Digitizing Rapid Biomanufacturing Processes: real-time process parameters do not sync with batch records. | Head of Manufacturing, Process Engineer | Route manufacturing data directly from equipment to electronic batch records. |
| Digitizing Rapid Biomanufacturing Processes: manual equipment calibration generates compliance risks. | Head of Manufacturing, Validation Engineer | Standardize automated equipment calibration schedules and logging. | |
| Digitizing Rapid Biomanufacturing Processes: raw material tracing fails across production stages. | Head of Supply Chain, Head of Manufacturing | Enforce end-to-end digital tracking of raw materials within the MES. | |
| Cold Chain Logistics Platforms | Orchestrating Specialized Cold Chain Logistics: temperature deviations occur during transit. | Head of Supply Chain, Logistics Manager | Detect temperature excursions with real-time sensor data. |
| Orchestrating Specialized Cold Chain Logistics: patient-specific shipments lack precise tracking updates. | Head of Supply Chain, Patient Services Manager | Standardize GPS location and condition monitoring for each shipment. | |
| Orchestrating Specialized Cold Chain Logistics: inventory reconciliation faces delays due to fragmented data. | Head of Supply Chain, Inventory Manager | Aggregate real-time inventory data from various storage locations. |
Identify when companies like Precigen are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Precigen’s digital transformation unique
Precigen’s digital transformation specifically prioritizes the integration of advanced manufacturing technologies with stringent GxP compliance requirements. Their approach focuses on creating rapid, decentralized production capabilities for highly individualized cell and gene therapies, which demands specialized software and hardware solutions beyond typical pharmaceutical manufacturing. This necessitates a unique emphasis on real-time process control and end-to-end digital traceability to ensure both product efficacy and patient safety for highly sensitive biological materials. The commercialization of PAPZIMEOS amplifies the need for integrated systems that connect R&D insights with market distribution, adding another layer of complexity.
Precigen’s Digital Transformation: Operational Breakdown
DT Initiative 1: Establishing Commercial Operations for PAPZIMEOS
What the company is doing
Precigen is building out its commercial infrastructure to support the launch and ongoing distribution of PAPZIMEOS. This involves setting up systems for order management, customer relationship management, and patient access programs. The company establishes channels for product distribution and post-market surveillance.
Who owns this
- Chief Commercial Officer
- Head of Sales Operations
- Head of Patient Services
- Head of Regulatory Affairs
Where It Fails
- Customer relationship management (CRM) systems do not integrate patient support case data.
- Order processing workflows require manual validation of insurance information.
- Inventory management systems do not communicate real-time stock levels for distribution centers.
- Post-market surveillance data fails to propagate into pharmacovigilance reporting systems.
Talk track
Noticed Precigen is establishing commercial operations for PAPZIMEOS. Been looking at how some biopharma teams are integrating patient support data directly into CRM systems instead of managing it separately, can share what’s working if useful.
DT Initiative 2: Digitizing Rapid Biomanufacturing Processes
What the company is doing
Precigen implements advanced automation and data capture within its manufacturing facilities, including its UltraPorator® system. This effort aims to accelerate the production of cell and gene therapies by digitizing process controls and integrating real-time operational data. The company focuses on ensuring consistency and scalability for its proprietary AdenoVerse® and UltraCAR-T® platforms.
Who owns this
- Head of Manufacturing
- VP, Process Development
- Validation Engineer
- Head of Quality Control
Where It Fails
- Automated bioreactor data does not synchronize with electronic batch records.
- Process monitoring sensors trigger false alarms when thresholds are met.
- Equipment maintenance schedules rely on manual tracking in the enterprise resource planning (ERP) system.
- Raw material lot numbers fail to trace automatically through the manufacturing execution system (MES).
Talk track
Saw Precigen is digitizing rapid biomanufacturing processes. Been looking at how some advanced therapy manufacturers are linking real-time process data directly to batch records instead of manual input, happy to share what we’re seeing.
DT Initiative 3: Streamlining Clinical Trial Data Management
What the company is doing
Precigen is enhancing its systems for collecting, managing, and analyzing data from its clinical trials. This includes efforts to standardize electronic data capture (EDC), improve data quality, and prepare comprehensive regulatory submissions. The company ensures compliance with Good Clinical Practice (GCP) guidelines.
Who owns this
- Head of Clinical Operations
- Clinical Data Manager
- Head of Biostatistics
- Head of Regulatory Affairs
Where It Fails
- Electronic data capture (EDC) systems produce inconsistencies during data transfers to statistical analysis software.
- Clinical trial management system (CTMS) workflows do not automatically flag overdue monitoring visits.
- Regulatory information management systems (RIMS) lack automatic version control for clinical study reports.
- Patient reported outcome (PRO) data does not integrate seamlessly with clinical trial databases.
Talk track
Looks like Precigen is streamlining clinical trial data management. Been seeing teams validate incoming data at the point of collection instead of correcting errors later, can share what’s working if useful.
DT Initiative 4: Digitalizing GxP Quality Management Systems
What the company is doing
Precigen transitions its quality management processes from manual or paper-based systems to electronic quality management systems (eQMS). This initiative covers document control, training management, deviation handling, corrective and preventive actions (CAPA), and audit management. The company aims to ensure continuous GxP compliance and audit readiness.
Who owns this
- Head of Quality Assurance
- Quality Systems Manager
- Head of Regulatory Affairs
- Compliance Officer
Where It Fails
- Document control workflows allow unapproved versions to circulate before final sign-off.
- Training records for staff do not automatically update completion status in the learning management system (LMS).
- Deviation investigations lack automated routing for timely review and approval.
- Audit management systems fail to link findings directly to corresponding corrective action preventive action (CAPA) records.
Talk track
Noticed Precigen is digitalizing GxP Quality Management Systems. Been looking at how some biopharma organizations enforce automated routing for deviation investigations instead of manual assignments, happy to share what we’re seeing.
Who Should Target Precigen Right Now
This account is relevant for:
- Electronic Quality Management System (eQMS) providers
- Clinical Trial Management System (CTMS) and EDC platform vendors
- Biomanufacturing Execution System (MES) and process control software vendors
- Specialized Cold Chain Logistics and Visibility platform providers
- Biopharmaceutical Data Integration and Analytics solution providers
- Regulatory Information Management System (RIMS) vendors
Not a fit for:
- Basic office productivity software providers
- Generic IT infrastructure consultants without biotech specialization
- Standard enterprise resource planning (ERP) vendors lacking GxP focus
- Consumer-facing marketing automation platforms
- General human resources management systems
- Physical security system vendors
When Precigen Is Worth Prioritizing
Prioritize if:
- You sell electronic quality management solutions that automate document control and deviation workflows in GxP environments.
- You sell clinical trial management platforms that enforce data quality standards during electronic data capture.
- You sell biomanufacturing execution systems that integrate real-time process data with electronic batch records.
- You sell specialized cold chain logistics platforms that provide real-time temperature monitoring and shipment tracking for patient-specific therapies.
- You sell data integration and analytics tools that centralize diverse R&D data for accelerated drug discovery in biopharma.
- You sell regulatory information management systems that automate the compilation of clinical data for BLA submissions.
Deprioritize if:
- Your solution does not address specific GxP compliance breakdowns or manufacturing automation failures.
- Your product is limited to basic data storage without advanced integration or validation capabilities.
- Your offering is not built for the unique demands of cell and gene therapy R&D, manufacturing, or logistics.
- Your solution focuses on general business processes rather than specialized biopharmaceutical workflows.
Who Can Sell to Precigen Right Now
Electronic Quality Management Systems
Veeva Systems - This company provides cloud-based software for the global life sciences industry, including quality management and regulatory solutions.
Why they are relevant: Precigen faces manual document control that generates version conflicts within its GxP quality management systems. Veeva QualityDocs can centralize document management, enforce version control, and automate review-and-approval workflows, ensuring compliance and reducing human error.
MasterControl - This company offers a comprehensive quality management system designed for regulated industries like life sciences.
Why they are relevant: Precigen's training records require manual updates and verification within its GxP quality management systems. MasterControl Training automates assignment, tracking, and verification of employee training, ensuring all personnel remain compliant with current protocols.
TrackWise (Sparta Systems, now Honeywell HLS) - This company provides enterprise quality management software that manages quality processes across the product lifecycle.
Why they are relevant: Precigen’s deviation investigations lack automated routing for timely review and approval within its GxP quality management systems. TrackWise can standardize deviation workflows, enforce routing, and ensure timely resolution, preventing delays in compliance.
Clinical Trial Management and Data Platforms
Medidata Solutions (Dassault Systèmes) - This company offers cloud-based solutions for clinical development, including electronic data capture and clinical trial management.
Why they are relevant: Precigen's electronic data capture (EDC) systems produce inconsistencies during data transfers to statistical analysis software. Medidata Rave EDC can validate data at the point of entry and standardize data formats for seamless integration with downstream analytics, preventing data quality issues.
IQVIA Technologies - This company provides technology solutions and analytics for clinical research and commercialization in the life sciences industry.
Why they are relevant: Precigen's regulatory submissions require extensive manual data compilation from clinical trials. IQVIA RegulatoryOne can automate data extraction and report generation, standardizing the BLA submission package and reducing manual effort for regulatory affairs.
Clinical ink - This company offers a platform for electronic clinical outcome assessment (eCOA) and direct data capture (DDC) in clinical trials.
Why they are relevant: Precigen's patient consent forms are not consistently tracked digitally within its clinical trial management workflows. Clinical ink can enforce digital consent capture, manage version control, and integrate consent status directly into the CTMS, ensuring compliance.
Biomanufacturing Execution and Process Control Systems
Werum IT Solutions (Körber) - This company provides a leading manufacturing execution system (MES) specifically designed for the pharmaceutical and biotech industries.
Why they are relevant: Precigen's automated bioreactor data does not synchronize with electronic batch records during biomanufacturing processes. Werum PAS-X MES can route real-time data directly from manufacturing equipment to batch records, enforcing data integrity and GxP compliance.
Emerson Process Management - This company offers automation solutions, including distributed control systems (DCS) and manufacturing execution systems for highly regulated industries.
Why they are relevant: Precigen's process monitoring sensors trigger false alarms when thresholds are met in biomanufacturing. Emerson DeltaV DCS can calibrate sensor thresholds, detect anomalies with greater precision, and prevent unnecessary interruptions to production.
Rockwell Automation - This company provides industrial automation and digital transformation solutions, including MES and quality management for life sciences.
Why they are relevant: Precigen’s raw material lot numbers fail to trace automatically through the manufacturing execution system. Rockwell Automation PharmaSuite MES can enforce end-to-end digital tracking of raw materials from receipt to final product, preventing traceability gaps.
Cold Chain Logistics and Supply Chain Visibility
FourKites - This company offers real-time visibility solutions for transportation and supply chains across various industries.
Why they are relevant: Precigen's temperature deviations occur during transit for specialized cold chain logistics. FourKites can detect temperature excursions with real-time sensor data and provide immediate alerts, enabling corrective actions to prevent product loss.
Tive - This company provides real-time in-transit visibility with tracking devices and cloud software for cold chain and high-value shipments.
Why they are relevant: Precigen's patient-specific shipments lack precise tracking updates within its cold chain logistics. Tive trackers can standardize GPS location and condition monitoring for each individual shipment, providing granular visibility and enhancing patient safety.
Sensitech (Carrier Global Corporation) - This company offers cold chain monitoring and data logging solutions for temperature-sensitive products.
Why they are relevant: Precigen’s inventory reconciliation faces delays due to fragmented data within specialized cold chain logistics. Sensitech’s data loggers and software can aggregate real-time temperature and location data from various storage and transit points, preventing discrepancies.
Final Take
Precigen is rapidly scaling its commercial and manufacturing operations for innovative gene and cell therapies. This growth exposes breakdowns in data integration across clinical, manufacturing, and quality systems. This account is a strong fit for sellers offering specialized GxP-compliant software and cold chain solutions that enforce data integrity and automate critical workflows.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.